FDA rejects Amphastar’s nasal opioid overdose treatment

Read more

Valeant Pharmaceuticals and EyeGate Enter into Licensing Agreement for EGP-437 Combination Product

Read more

Abzena signs antibody manufacturing development deal with University College London

Read more

Xbrane Biopharma obtains GMP certification for Spherotide production facility

Read more

ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials

Read more

CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement

Read more

Immune Pharmaceuticals Announces the launch of REMAIN

Read more

FDA accepts Intellipharmaceutics’ NDA for Rexista to treat moderate to severe pain

Read more

Momenta announces FDA warning letter to contracted Glatopa’s fill/finish manufacturer

Read more

Arix Bioscience raises £100m in IPO

Read more